Abstract:Human induced pluripotent stem cell (hiPSC)-derived cardiac organoids (COs) have shown great potential in modelling human heart development and cardiovascular diseases, a leading cause of global death. However, several limitations such as low reproducibility, limited vascularization and difficulty in formation of cardiac chamber were yet to be overcome. We established a new method for robust generation of COs, via combination of methodologies of hiPSC-derived vascular spheres and directly differentiated cardiomyocytes from hiPSCs, and investigated the potential application of human COs in cardiac injury modelling and drug evaluation. The human COs we built displayed a vascularized and chamber-like structure, and hence were named vaschamcardioids (vcCOs). These vcCOs exhibited approximately 90% spontaneous beating ratio. Single-cell transcriptomics identified a total of six cell types in the vcCOs, including cardiomyocytes, cardiac precursor cells, endothelial cells, fibroblasts, etc. We successfully recaptured the processes of cardiac injury and fibrosis in vivo on vcCOs, and showed that the FDA-approved medication captopril significantly attenuated cardiac injury-induced fibrosis and functional disorders. In addition, the human vcCOs exhibited an obvious drug toxicity reaction to doxorubicin in a dose-dependent manner. We developed a three-step method for robust generation of chamber-like and vascularized complex vcCOs, and our data suggested that vcCOs might become a useful model for understanding pathophysiological mechanisms of cardiovascular diseases, developing intervention strategies and screening drugs.

Revolutionizing Cardiovascular Research: Human Organoids as a Beacon of Hope for Understanding and Treating Cardiovascular Diseases

Advances in Cardiac Organoids

Promises and Challenges of Cardiac Organoids

Cardiac Organoids: A 3D Technology for Disease Modeling and Drug Screening.

Angiorganoid: Vitalizing the Organoid with Blood Vessels.

Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease

Recent Advances and Future Perspectives in Vascular Organoids and Vessel-on-Chip

Cardiac Organoid — a Promising Perspective of Preclinical Model

Review on the Vascularization of Organoids and Organoids-on-a-Chip

Vascular organoids: unveiling advantages, applications, challenges, and disease modelling strategies

Research Progress, Challenges, and Breakthroughs of Organoids as Disease Models

Engineering vascularised organoid-on-a-chip: strategies, advances and future perspectives

Organoid technology for tissue engineering

Unveiling New Horizons in Heart Research: the Promise of Multi-Chamber Cardiac Organoids

Human organoids in basic research and clinical applications

Vascularized Organoids: A More Complete Model

Organ-on-a-chip technology: a novel approach to investigate cardiovascular diseases

Self-assembly vascularized human cardiac organoids model cardiac diseases in petri dishes and in mice

Generation of Human Vascularized and Chambered Cardiac Organoids for Cardiac Disease Modelling and Drug Evaluation.

Recent progress of organ-on-a-chip towards cardiovascular diseases: advanced design, fabrication, and applications

Organoids as preclinical models of human disease: progress and applications